Phibro Animal Health Corporation (NASDAQ:PAHC) insider Jack Bendheim sold 48,000 shares of the company’s stock in a transaction dated Friday, June 23rd. The stock was sold at an average price of $37.15, for a total transaction of $1,783,200.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Jack Bendheim also recently made the following trade(s):

  • On Friday, June 9th, Jack Bendheim sold 48,000 shares of Phibro Animal Health Corporation stock. The stock was sold at an average price of $35.62, for a total transaction of $1,709,760.00.
  • On Thursday, May 25th, Jack Bendheim sold 48,000 shares of Phibro Animal Health Corporation stock. The stock was sold at an average price of $34.67, for a total transaction of $1,664,160.00.
  • On Friday, May 19th, Jack Bendheim sold 48,000 shares of Phibro Animal Health Corporation stock. The stock was sold at an average price of $34.15, for a total transaction of $1,639,200.00.
  • On Wednesday, May 10th, Jack Bendheim sold 1,400 shares of Phibro Animal Health Corporation stock. The stock was sold at an average price of $34.04, for a total transaction of $47,656.00.

Phibro Animal Health Corporation (PAHC) traded up 1.21% during mid-day trading on Friday, hitting $37.65. 247,583 shares of the stock were exchanged. The company has a market cap of $1.49 billion, a P/E ratio of 23.39 and a beta of 1.35. The company has a 50-day moving average price of $34.12 and a 200-day moving average price of $29.74. Phibro Animal Health Corporation has a one year low of $17.96 and a one year high of $37.70.

Phibro Animal Health Corporation (NASDAQ:PAHC) last announced its quarterly earnings data on Monday, May 8th. The company reported $0.37 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.37. Phibro Animal Health Corporation had a net margin of 8.49% and a return on equity of 54.68%. The firm had revenue of $190 million during the quarter, compared to analysts’ expectations of $185.90 million. During the same quarter last year, the business earned $0.38 earnings per share. The business’s revenue for the quarter was up 3.5% compared to the same quarter last year. Analysts forecast that Phibro Animal Health Corporation will post $1.45 earnings per share for the current fiscal year.

Insider Buying and Selling by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 22nd. Investors of record on Wednesday, May 31st were paid a $0.10 dividend. This represents a $0.40 annualized dividend and a dividend yield of 1.06%. The ex-dividend date of this dividend was Friday, May 26th. Phibro Animal Health Corporation’s dividend payout ratio (DPR) is 24.69%.

WARNING: “Insider Selling: Phibro Animal Health Corporation (PAHC) Insider Sells 48,000 Shares of Stock” was first published by Watch List News and is the property of of Watch List News. If you are accessing this report on another website, it was illegally copied and republished in violation of US & international copyright & trademark legislation. The correct version of this report can be accessed at https://www.watchlistnews.com/insider-selling-phibro-animal-health-corporation-pahc-insider-sells-48000-shares-of-stock/1389360.html.

Several hedge funds have recently made changes to their positions in the stock. Mason Street Advisors LLC boosted its stake in shares of Phibro Animal Health Corporation by 7.1% in the first quarter. Mason Street Advisors LLC now owns 4,333 shares of the company’s stock valued at $122,000 after buying an additional 286 shares during the period. Victory Capital Management Inc. boosted its stake in shares of Phibro Animal Health Corporation by 79.2% in the first quarter. Victory Capital Management Inc. now owns 4,573 shares of the company’s stock valued at $129,000 after buying an additional 2,021 shares during the period. Louisiana State Employees Retirement System boosted its stake in shares of Phibro Animal Health Corporation by 1.4% in the first quarter. Louisiana State Employees Retirement System now owns 7,500 shares of the company’s stock valued at $211,000 after buying an additional 100 shares during the period. CAPROCK Group Inc. bought a new stake in shares of Phibro Animal Health Corporation during the first quarter valued at approximately $213,000. Finally, New York State Teachers Retirement System boosted its stake in shares of Phibro Animal Health Corporation by 1.4% in the fourth quarter. New York State Teachers Retirement System now owns 7,343 shares of the company’s stock valued at $215,000 after buying an additional 100 shares during the period. Hedge funds and other institutional investors own 47.60% of the company’s stock.

A number of brokerages have weighed in on PAHC. BidaskClub upgraded shares of Phibro Animal Health Corporation from a “buy” rating to a “strong-buy” rating in a research report on Thursday. Credit Suisse Group downgraded shares of Phibro Animal Health Corporation from an “outperform” rating to a “neutral” rating and upped their price objective for the stock from $29.00 to $36.00 in a research report on Friday, June 2nd. Finally, Zacks Investment Research upgraded shares of Phibro Animal Health Corporation from a “hold” rating to a “buy” rating and set a $38.00 price objective for the company in a research report on Thursday, May 11th. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. Phibro Animal Health Corporation presently has a consensus rating of “Hold” and an average price target of $30.33.

Phibro Animal Health Corporation Company Profile

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.